TickerFacts.

Celldex Therapeutics, Inc. (CLDX): EPS (Basic)

Annual figures by period end, from SEC filings.

-$3.90
Year ended 2025-12-31
2019-12-31: -$3.512020-12-31: -$2.022021-12-31: -$1.642022-12-31: -$2.402023-12-31: -$2.922024-12-31: -$2.452025-12-31: -$3.90-$3.90
2019-12-31 EPS (Basic) (USD per share) 2025-12-31
Period endedEPS (Basic)Change YoYSource filing
2025-12-31-$3.90n/m2026-02-25, From 2025-01-01
2024-12-31-$2.45n/m2026-02-25, From 2024-01-01
2023-12-31-$2.92n/m2026-02-25, From 2023-01-01
2022-12-31-$2.40n/m2025-02-27, From 2022-01-01
2021-12-31-$1.64n/m2024-02-26, From 2021-01-01
2020-12-31-$2.02n/m2023-02-28, From 2020-01-01
2019-12-31-$3.51n/a2022-02-28, From 2019-01-01

EPS (Basic) at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEPS (Basic)Change YoY
Celldex Therapeutics, Inc. (CLDX)2025-12-31-$3.90n/m
Insight Molecular Diagnostics Inc. (IMDX)2025-12-31-$1.65n/m
Biomerica Inc (BMRA)2026-05-31-$1.30n/m
Anbio Biotechnology (NNNN)2025-12-31$0.15+162.5%
Aspira Women's Health Inc. (AWHL)2025-12-31-$0.37n/m
Immucell Corp (ICCC)2025-12-31-$0.12n/m
Alpha Teknova, Inc. (TKNO)2025-12-31-$0.32n/m
Intellia Therapeutics, Inc. (NTLA)2025-12-31-$3.81n/m
Cardio Diagnostics Holdings, Inc. (CDIO)2025-12-31-$3.71n/m

Compare CLDX, IMDX, BMRA, NNNN side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗